Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-11 Purchase | 2025-03-11 6:42 pm | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 343,631 | $2.16 | $742,243 | 56,143,640 (Direct) | View |
| 2025-03-10 Purchase | 2025-03-10 5:11 pm | AbCellera Biologics Inc. | ABCL | Montalbano John S. Director | 25,000 | $2.3 | $57,500 | 176,000 (Indirect Direct) | View |
| 2025-03-06 Purchase | 2025-03-07 3:32 pm | AbCellera Biologics Inc. | ABCL | Montalbano John S. Director | 60,000 | $2.3428 | $140,568 | 151,000 (Indirect Direct) | View |
| 2024-08-29 Purchase | 2024-08-29 4:35 pm | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 283,516 | $2.61 | $739,977 | 56,086,009 (Direct) | View |
| 2023-11-06 Purchase | 2023-11-08 3:29 pm | AbCellera Biologics Inc. | ABCL | Montalbano John S. Director | 30,000 | $4.58 | $137,400 | 91,000 (Indirect Direct) | View |
| 2023-09-22 Purchase | 2023-09-26 12:26 pm | AbCellera Biologics Inc. | ABCL | Hayden Michael R Director | 20,000 | $4.91 | $98,200 | 1,441,642 (Indirect) | View |
| 2023-09-12 Purchase | 2023-09-14 4:38 pm | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 20,000 | $5.19 | $103,800 | 9,530,340 (Indirect Direct) | View |
| 2023-08-08 Purchase | 2023-08-09 12:22 pm | AbCellera Biologics Inc. | ABCL | Hayden Michael R Director | 30,000 | $5.9 | $177,000 | 1,421,642 (Indirect) | View |
| 2023-05-26 Purchase | 2023-05-26 2:53 pm | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 14,500 | $6.85 | $99,325 | 283,959 (Indirect Direct) | View |
| 2023-05-26 Purchase | 2023-05-26 2:50 pm | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 153,000 | $6.5211 | $997,728 | 56,012,493 (Direct) | View |
| 2022-12-16 Purchase | 2022-12-20 10:18 am | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 85,102 | $10.1 | $859,249 | 55,859,493 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-01 Option Award | 2025-01-03 3:44 pm | N/A 2035-01-01 | AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer | 832,033 | $0 | 4,106,747 (Direct) | View |
| 2025-01-01 Option Award | 2025-01-03 3:40 pm | N/A 2035-01-01 | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 832,033 | $0 | 4,661,804 (Direct) | View |
| 2025-01-01 Option Award | 2025-01-03 3:37 pm | N/A 2035-01-01 | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 1,352,054 | $0 | 7,942,951 (Direct) | View |
| 2025-01-01 Option Award | 2025-01-03 3:36 pm | N/A 2035-01-01 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 2,730,109 | $0 | 10,990,332 (Direct) | View |
| 2024-12-04 Gift | 2024-12-05 4:47 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 286,000 | $0 | 55,800,009 (Direct) | View |
| 2024-11-25 Exercise | 2024-11-26 5:38 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 65,244,232 (Direct) | View |
| 2024-11-25 Exercise | 2024-11-26 5:38 pm | N/A 2030-11-27 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 65,244,232 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 4:09 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 65,244,232 (Direct) | View |
| 2024-09-20 Exercise | 2024-09-24 4:09 pm | N/A 2030-11-27 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 65,244,232 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-24 6:38 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 83,334 | $0.188 | 13,443,445 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-24 6:38 pm | N/A 2027-03-23 | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 83,334 | $0 | 13,443,445 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-24 6:30 pm | 2025-06-12 2034-06-21 | AbCellera Biologics Inc. | ABCL | Hayden Michael R Director | 163,934 | $0 | 660,979 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-24 6:19 pm | 2025-06-12 2034-06-21 | AbCellera Biologics Inc. | ABCL | Lo Andrew Director | 163,934 | $0 | 302,490 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-24 6:15 pm | 2025-06-12 2034-06-21 | AbCellera Biologics Inc. | ABCL | Montalbano John S. Director | 163,934 | $0 | 790,979 (Direct) | View |
| 2024-05-31 Exercise | 2024-06-03 4:21 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 64,960,716 (Direct) | View |
| 2024-05-31 Exercise | 2024-06-03 4:21 pm | N/A 2030-11-27 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 64,960,716 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-27 2:12 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 64,960,716 (Direct) | View |
| 2024-02-26 Exercise | 2024-02-27 2:12 pm | N/A 2030-11-27 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 64,960,716 (Direct) | View |
| 2024-01-14 Option Award | 2024-01-16 6:23 pm | N/A 2034-01-14 | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 770,416 | $0 | 3,913,105 (Direct) | View |
| 2024-01-14 Option Award | 2024-01-16 6:21 pm | N/A 2034-01-14 | AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer | 616,333 | $0 | 3,274,714 (Direct) | View |
| 2024-01-14 Option Award | 2024-01-16 6:18 pm | N/A 2034-01-14 | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 770,416 | $0 | 6,590,897 (Direct) | View |
| 2024-01-14 Option Award | 2024-01-16 6:14 pm | N/A 2034-01-14 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 2,095,532 | $0 | 8,484,723 (Direct) | View |
| 2023-12-19 Gift | 2023-12-19 6:08 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Thermopylae Holdings Ltd. 10% Owner | 210,000 | $0 | 55,802,493 (Direct) | View |
| 2023-11-23 Exercise | 2023-11-27 4:45 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 63,075,184 (Direct) | View |
| 2023-11-23 Exercise | 2023-11-27 4:45 pm | N/A 2030-11-27 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 63,075,184 (Direct) | View |
| 2023-08-24 Exercise | 2023-08-25 1:57 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 63,075,184 (Direct) | View |
| 2023-08-24 Exercise | 2023-08-25 1:57 pm | N/A 2030-11-27 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 63,075,184 (Direct) | View |
| 2023-05-26 Exercise | 2023-05-30 1:14 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 63,075,184 (Direct) | View |
| 2023-05-26 Exercise | 2023-05-30 1:14 pm | N/A 2030-11-18 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 63,075,184 (Direct) | View |
| 2023-05-05 Exercise | 2023-05-09 3:02 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 250,000 | $0.19 | 12,653,029 (Direct) | View |
| 2023-05-05 Exercise | 2023-05-09 3:02 pm | N/A 2027-03-23 | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 250,000 | $0 | 12,653,029 (Direct) | View |
| 2023-02-22 Exercise | 2023-02-23 4:33 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $2.7 | 62,922,184 (Direct) | View |
| 2023-02-22 Exercise | 2023-02-23 4:33 pm | N/A 2030-11-18 | AbCellera Biologics Inc. | ABCL | Hansen Carl L. G. Chief Executive Officer 10% Owner | 56,125 | $0 | 62,922,184 (Direct) | View |
| 2022-12-20 Gift | 2022-12-22 2:31 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 50,000 | $0 | 6,089,940 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-22 2:31 pm | N/A N/A | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 50,000 | $0.19 | 6,089,940 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-22 2:31 pm | N/A 2026-06-15 | AbCellera Biologics Inc. | ABCL | Booth Andrew Chief Financial Officer | 50,000 | $0 | 6,089,940 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:34 pm | 2024-06-15 2032-12-01 | AbCellera Biologics Inc. | ABCL | Lo Andrew Director | 47,231 | $0 | 138,556 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:33 pm | 2024-06-15 2032-12-01 | AbCellera Biologics Inc. | ABCL | Hayden Michael R Director | 47,231 | $0 | 497,045 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:30 pm | 2024-06-15 2032-12-01 | AbCellera Biologics Inc. | ABCL | Montalbano John S. Director | 47,231 | $0 | 627,045 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:28 pm | N/A 2032-12-01 | AbCellera Biologics Inc. | ABCL | Lecault Veronique Chief Operating Officer | 462,535 | $0 | 3,392,689 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 12:22 pm | N/A 2032-12-01 | AbCellera Biologics Inc. | ABCL | Stimart Tryn Chief Legal Officer | 346,901 | $0 | 2,658,381 (Direct) | View |